Executive record

Eric Hyllengren, M.B.A.

Eric Hyllengren, M.B.A. holds the CFO seat at Tenaya Therapeutics, Inc. on the record, Chief Financial Officer, effective July 13, 2026.

1 verified record · 1 company · current seat on the record: Tenaya Therapeutics, Inc.

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-06-29TransitionTenaya Therapeutics, Inc.current seat

    Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.

    Named as the incoming officer, Chief Financial Officer

    effective July 13, 2026 · 8-K filed June 29, 2026 · sec.gov, Item 5.02

Companies

1

Tenaya Therapeutics, Inc.TNYA

Biological Products, (No Diagnostic Substances)

This page lists only verified filing records that name Eric Hyllengren, M.B.A., matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.